AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Well, Now
The Full Truth About Ozempic
Jul 10, 2024
Harvard professor Dr. Fatima Cody Stanford discusses GLP-1 agonist drugs like Ozempic, their impact on weight management, personalized healthcare approaches, challenges with access to medication, and the importance of seeking proper medical treatment for obesity.
49:39
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- GLP-1 agonist drugs like Ozempic offer significant weight loss benefits for adults with obesity, revolutionizing obesity medicine.
- GLP-1 medications demonstrate a remarkable safety profile with benefits including cardio protection and favorable outcomes for kidney health.
Deep dives
Introduction to GLP-1 Medications
GLP-1 medications have revolutionized obesity medicine, offering significant weight loss benefits for adults with obesity or weight-related conditions. The FDA's approval of semaglutide injection marked a milestone, impacting the landscape of obesity medicine. This class of drugs, including drugs like Ozempic and Wegovy, is changing how obesity is treated and the number of American adults benefiting from these medications is increasing significantly.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode